Intravenous regional anesthesia (IVRA) is mainly used in surgical operations with predicted durations of \<1 h. Although this technique is useful for fractures of the upper extremity, especially distal to the elbow, and relieves the need for general anesthesia, it is limited by pain resulting from the application of tourniquets and postoperative pain ([@b1-prm-19-e154]--[@b3-prm-19-e154]). Increasing the efficacy of pain control in IVRA has been attempted by several authors, who have studied the addition of drugs, such as dexmedetomidine, dexamethasone, ketorolac and melatonin, to lidocaine in IVRA protocols, and reported enhanced anesthesia time and reduced pain perceived by patients ([@b4-prm-19-e154]--[@b7-prm-19-e154]).

Rather than these pharmacological interventions, we have used low-level laser therapy (LLLT) as an adjunct to the standard IVRA protocol. In recent years, and following Food and Drug Administration approval of LLLT ([@b8-prm-19-e154],[@b9-prm-19-e154]) for pain relief, the practice has become relatively common. Although the exact mechanism of LLLT is not fully understood, there is evidence that LLLT activates many local analgesic mechanisms that affect perception of pain ([@b10-prm-19-e154],[@b11-prm-19-e154]). Thus, some researchers have implemented the LLLT protocols in their studies to determine whether this approach is effective in pain management. For example, low-power irradiation was successfully used to treat pain due to lateral elbow tendinopathy ([@b12-prm-19-e154]) and pain associated with knee osteoarthritis ([@b13-prm-19-e154]). Postoperative pain management has also been studied in attempts to provide evidence in favour of or against the efficacy of LLLT in surgical settings. For instance, pain management and administration of analgesics were improved after low-power red laser irradiation in breast augmentation surgery ([@b14-prm-19-e154]), cryosurgical treatment of leukoplakia ([@b15-prm-19-e154]) and cholecystectomy ([@b16-prm-19-e154]). LLLT was also beneficial in reducing complications of surgical procedures such as lymphedema after mastectomy ([@b17-prm-19-e154],[@b18-prm-19-e154]).

The aim of the present study was to assess the efficacy of pretreatment with gallium-aluminum-arsenide (Ga-Al-As) irradiation as an adjunct to IVRA in terms of the pain perceived by patients during and after the operation, and the need for opioid administration in the surgical fixation of distal radius fractures.

METHODS
=======

The present study was a double-blinded, placebo-controlled, randomized clinical trial involving 48 patients with distal radius fracture eligible for pin-casting surgery (code: IRCT2012081810509N3). To the authors' knowledge, the present study is the first to publish such results. The present study was conducted at the Imam Khomeini Hospital, Ahvaz, Iran, from 2012 to 2013. The Ethics Committee of Jundishapur University of Medical Sciences (Ahvaz, Iran) approved the study, and informed written consent was obtained from all participants after full disclosure of the purpose of the study (code: ETH-441). The inclusion criteria were based on the American Society of Anesthesiology physical status classification system. Patients who were classified as American Society of Anesthesiology physical status class I or II, with distal radius fracture, who were between 18 and 50 years of age were included in the study. Exclusion criteria are presented in [Table 1](#t1-prm-19-e154){ref-type="table"}.

Using a random numbers table and random digits, participants were assigned to two groups: a placebo (ie, control) group (n=24) and a laser-assisted group (n=24). The study was double blinded -- the patients and therapist (anesthesia resident) who completed the questionnaires were blinded to the patient groups and did not know the study groups. Only the operator of the LLLT was aware of the study group.

The method used to provide anesthesia was essentially the same for both groups. An intravenous (IV) line was established in the dorsal vein of the fractured extremity as distal as possible to the surgical site to inject anesthetics. Another IV line was placed in the other hand to infuse crystalloid fluids and 0.03 mg/kg midazolam. To vacate blood from the surgical site, the affected upper limb was elevated for 2 min and then wrapped with an elastic band. Subsequently, a double-cuffed tourniquet was applied around the upper arm. The proximal cuff was inflated to 300 mmHg immediately before removing the elastic band. The absence of radial artery pulses and pulse oximetry waves were considered to be evidence of the success of this procedure. Both groups received 2% lidocaine (3 mg/kg, diluted by normal saline to 40 mL) through an intravenous line in the affected extremity (Aburaihan Pharmaceutical Co, Iran).

The laser-assisted group received irradiation via a continuous-wave Ga-Al-As device (Canadian Optic and Laser Production Center, Canada). The specifications of this device include the following: wavelength 808 nm, power 200 mW, power density 0.8 W/cm^2^ and contact area 0.25 cm^2^. Immediately after the proximal cuff was inflated, patients received 4 J/point contact laser irradiation over three nerve roots from C5 to C8 vertebrae on the affected side, for 20 s over each point. Furthermore, they received 0.1 J/cm^2^ tangential scanning irradiation on the affected limb for a total of 5 min from the lower border of the tourniquet through the forearm, wrist and fingers ([Figure 1](#f1-prm-19-e154){ref-type="fig"}). The control group received the same protocol and timing of laser probe application with the laser switched off. Sensory block was tested every 30 s by pinprick test (22 gauge) in the median, lateral cutaneous, ulnar and radial nerve territories. When complete anesthesia was achieved, the distal cuff was inflated to 300 mmHg and the proximal cuff was deflated.

O~2~ saturation, mean arterial pressure (MAP) and heart rate (HR) were measured before and immediately after inflation of the distal cuff, and then every 10 min for five additional measurements. The time to first request for pain relief by the patient was recorded. Moreover, pain severity was measured using a visual analogue scale (VAS) within the operation. If the VAS score was ≥3, 1 μg/kg fentanyl was infused immediately. If pain was not controlled adequately, general anesthesia was implemented and the patient was excluded from the study. The total surgical duration, duration of cuff inflation and total amount of fentanyl administered to patients were recorded. The cuff was not deflated before 30 min and was not kept inflated for \>90 min.The deflation was implemented every 10 s at the end of operation. If the postoperative VAS score was \>3, 20 mg pethidine was injected intravenously. The time to first request for postoperative pain relief and the total amount of pethidine administered were recorded in the 24 h after the operation.

Patients were evaluated for possible side effects such as hypertension or hypotension, bradycardia or tachycardia, hypoxia, tinnitus, headache, nausea and vomiting, vertigo, fatigue, arrhythmia, somnolence, bleeding at the site of operation and paresthesia.

The following statistics were used for calculating sample size: $$\text{N} = \frac{\left( {\text{Z}_{1 - \frac{\text{a}}{\text{z}}} + \text{Z}_{1 - ß}} \right)^{2}\left( {\text{P}_{1}\left( {1 - \text{P}_{1}} \right) + \text{P}_{2}\left( {1 - \text{P}_{2}} \right)} \right)}{\left( {\text{P}_{1} - \text{P}_{2}} \right)^{2}}$$

95% confidence with 80% power was assigned and, according to previous studies, P~1~ = 74 and P~2~ = 37 ([@b13-prm-19-e154]).

Data were analyzed using SPSS version 20 (IBM Corporation, USA). *t* tests and χ^2^ tests were used for comparison of quantitative and qualitative results, respectively.

RESULTS
=======

A total of 48 participants completed the study. Anthropometric characteristics of the study population are presented in [Table 2](#t2-prm-19-e154){ref-type="table"}. Men outnumbered women by threefold (77.1% versus 22.9%), which may be accounted for by traumatic events occurring in this age group.

MAP and HR were measured just before and after inflation of the tourniquet, and at 5 min, 10 min, 20 min, 30 min, 40 min and 50 min into the operation. The analysis demonstrated that there was no significant difference between the lidocaine-only group and the laser-assisted group in terms of MAP and HR ([Table 3](#t3-prm-19-e154){ref-type="table"}). The arterial saturation of O~2~ was 100% at all measurements in both groups.

The level of pain perceived by patients was assessed using a VAS. The measurements were performed before and after inflation of the tourniquet, and 5 min, 10 min, 20 min, 30 min, 40 min and 50 min into the operation ([Figure 2](#f2-prm-19-e154){ref-type="fig"}). Measurements were then extended to 2 h, 4 h, 8 h, 12 h and 24 h after operation ([Figure 3](#f3-prm-19-e154){ref-type="fig"}). No subjects reported pain before inflation of the tourniquet. The analysis showed significantly lower levels of pain in the laser-assisted group for all measurements ([Table 4](#t4-prm-19-e154){ref-type="table"}).

The mean time to the first request for pain relief during operation (fentanyl infusion) was 35±5 min for the laser-assisted group and 15±6.87 min for the lidocaine-only group. This difference reached statistical significance (P=0.04); also, the total dose of fentanyl infused in the laser-assisted group was lower (20.74±10.41 μg) than that of the lidocaine-only group (104.16±44.02 μg) (P=0.003).There was also a significant difference between groups in terms of the need for postoperative pain relief (pethidine injection). The mean time for the first request of pethidine was 186±45.6 min in the laser-assisted group and 24.05±23.7 min in the lidocaine-only group (P=0.002). The total amount of pethidine injected postoperatively was 13.3±11.2 mg in the laser-assisted group and 38.3±18.5 mg in the lidocaine-only group, which was significantly lower in the former (P=0.001).

DISCUSSION
==========

The results of our study showed that adding Ga-Al-As laser irradiation (808 nm) to IV lidocaine enhances the efficacy of regional anesthesia in terms of perceived pain and reduction of the need for opioid agents. The IVRA is especially constrained by tourniquet-induced pain and the postoperative pain resulting from diminished effects of the lidocaine. Importantly, the laser-assisted group needed both fentanyl and pethidine for anesthesia at a later time during and after operation, respectively, than did the lidocaine-only group. The same conclusion could be drawn for the total dose of fentanyl and pethidine administered for pain management postoperatively. This may be considered to be the effects of the laser irradiation protocol. It is important to note that no side effects were reported by patients at any time during the study.

The clinical application of LLLT for the treatment of acute and chronic pain is now well documented. Whereas the analgesic effects of LLLT has been studied for management of musculoskeletal pain and postoperative pain ([@b10-prm-19-e154]--[@b16-prm-19-e154]), our search revealed no published clinical trials regarding the addition of a laser protocol to IVRA in hand surgery. It has been shown that the pretreatment of the skin with a low-level laser followed by a 5 min topical lidocaine 4% diminished the pain of intravenous cannulation in adult and pediatric patients ([@b19-prm-19-e154],[@b20-prm-19-e154]). Laser therapy on surgical sites has been suggested to reduce the amount of analgesic drug consumption during surgery and pain after surgery. Jackson et al ([@b14-prm-19-e154]) studied 104 patients in Russia who underwent breast augmentation surgery and found that irradiation with a 630 nm to 640 nm low-power laser at the beginning and at the end of operation resulted in less postoperative pain and less analgesic consumption during the first week after surgery. In a controlled study by Moore et al ([@b16-prm-19-e154]) in England, 22 patients underwent cholecystectomy and received Ga-Al-As (830 nm) irradiation in a continuous mode. The results revealed a significant 50% reduction in postoperative pain in the laser group, with less analgesic consumption.

Koszowski et al ([@b21-prm-19-e154]) reported the comparison of analgesic effect of magnetic and laser stimulation before oral procedures. Laser stimulation and alternating magnetic field applied directly before oral surgery were-shown to be effective as analgesic agents to decrease intra- and postoperative sensations. Patients with high levels of stomatological fear were found to be more prone to sensation of pain; however, even in this group, laser and magnetic stimulation significantly reduced this complication. Results of a pilot study by Jonsson ([@b22-prm-19-e154]) demonstrated that fewer patients returned for postoperative redressing and complained of postoperative pain when laser therapy was offered as a part of surgical regimen to assist with postoperative healing after digital surgery (Winograd-type partial matrixectomy of the hallux).

The Food and Drug Administration's approval of the analgesic effect of laser therapy was motivation to assess its application as part of a perioperative plan for pain management. The most commonly used analgesic drugs after surgery are opioids and nonsteroidal anti-inflammatory drugs (NSAIDs). All opioids have been used to produce analgesia either before or after surgery. Common side effects of opioids include problems with breathing, apnea, nausea and vomiting, sleepiness, difficulty in thinking clearly, constipation, gradual overdose, and synergism with sedatives, anticonvulsants and local anesthetics that may increase their respective side effects. The most common recovery complications are attributed to narcotics. NSAIDs are typically used after surgery and it is recognized that the use of NSAIDs increases the risk of gastrointestinal bleeding, heart attacks and strokes. Finding a safe analgesia method with no side effects is always a main goal for anesthesiology. Laser therapy is an approved safe and noninvasive method for pain control, according to various studies. It appears that the summation of the analgesic effect of laser therapy and local anesthetic can increase the duration of anesthesia and the analgesic effect of drugs, while reducing drug consumption and, thus, eliminating complications due to drugs.

One limitation to our study was that we could not document the exact onset of sensory and motor block because of the elapsed time resulting from irradiation. Our study also did not determine whether long-term mobility outcomes were different between groups.

Over the past decade, considerable evidence has emerged for the positive effects of LLLT in the field of pain management. Here, we assessed this therapy in distal radius fractures and, according to our results, determined that addition of Ga-Al-As laser irradiation to lidocaine-induced regional anesthesia is an effective and safe means to reduce pain and analgesic consumption during hand surgery.
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![Schematic comparison of visual analogue scale scores between the lidocaine-only group (blue) and the laser-assisted group (green) during operation. Vertical axis shows visual analogue scale scores and horizontal axis shows time in min](prm-19-e154-2){#f2-prm-19-e154}
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###### 

Exclusion criteria for the study population

  -----------------------------------------------------
  Reynaud's phenomenon
  Systemic sclerosis
  Sickle cell anemia
  Diabetes mellitus
  Renal failure
  Hepatic dysfunction
  Pregnancy
  Malignancy
  Benign tumours with malignant potential
  Photosensitivity (eg, systemic lupus erythematosus)
  History of convulsions
  -----------------------------------------------------

###### 

Baseline characteristics of the study population

                               **Group (n=24)**                
  ---------------------------- ------------------ ------------ ------
  Age, years                   35.3±8.9           34.5±7.8     0.7
  Sex, n (%)                                                   
    Male                       21 (87.5)          17 (70.83)   
    Female                     3 (12.5)           7 (29.16)    
  Weight, kg                   71.04±6.9          71.6±6.6     0.76
  Height, cm                   168.7±5.38         168.5±5.59   0.89
  Duration of inflation, min   39.7±6.8           41.3±5.9     0.4

Data presented as mean ± SD unless otherwise indicated

###### 

Heart rate and mean arterial pressure of the participants during operation

                     **Heart rate**   **Mean arterial pressure**                                      
  ------------------ ---------------- ---------------------------- ------ ------------- ------------- ------
  Before inflation   87.5±9.13        84.7±9.07                    0.2    102.31±9.6    102.97±7.02   0.78
  After inflation    89.04±9.34       87.1±9.16                    0.06   100.6±5.7     99.41±9.51    0.6
  5 min              89.7±7.08        86.7±9.01                    2      101.6±11      99.5±8.7      0.6
  10 min             87.87±6.47       87.29±8.81                   0.79   96.03±10.1    100.59±7.17   0.8
  20 min             90.29±6.5        88.9±5.7                     0.4    97.83±11.2    101.38±7.9    0.21
  30 min             89.6±6.1         86.5±7.4                     0.13   96.2±12       101.04±8.9    0.12
  40 min             90.2±8           87.9±7.1                     0.3    96.5±13.7     102.1±8.7     0.09
  50 min             90.95±7.6        87.7±6.7                     0.12   98.16±10.39   102.1±9.02    0.16

Data presented as mean ± SD unless otherwise indicated

###### 

Visual analogue scale scores during and after operation

  **Time interval**    **Group (n=24 per group)**                
  -------------------- ---------------------------- ------------ -------
  5 min                0.2±0.04                     1.04±0.8     0.04
  10 min               0.2±0.03                     2.08±1.24    0.001
  20 min               0.58±0.45                    2.37± 1.13   0.02
  30 min               0.7±0.33                     3±0.97       0.02
  40 min               0.77±0.54                    3.7±1.85     0.03
  50 min               0.7±0.45                     2.58±1.34    0.01
  2 h postoperation    1.41±0.71                    6.2±1.38     0.03
  4 h postoperation    2±0.97                       3.45±0.88    0.01
  8 h postoperation    0.83±0.63                    1.7±0.55     0.001
  12 h postoperation   0.58±0.50                    1.37±0.49    0.03
  24 h postoperation   0.44±0.25                    0.66±0.48    0.003

Data presented as mean ± SD unless otherwise indicated.

P\<0.05, statistically significant
